Corbevax gets nod as COVID19 booster dose.

June 6, 2022

The Drug Controller General of India (DCGI) has approved Hyderabad based Biological E. Limited (BE)’s COVID19 vaccine Corbevax as a COVID19 booster dose.
The vaccine be administered to adults six months after the administration of second dose of Covaxin or Covishield for restricted use in emergency situations.
According to the company, Corbevax is India’s first approved heterologous COVID booster (when the third dose is different from earlier doses). Be hasn’t received who’s emergency use listing for the jab.
WHO’s EUL procedure assesses the quality, safety and efficacy of COVID19 vaccines and is a prerequisite for COVAX vaccine supply.

Corbevax gets nod as COVID­19 booster dose.